09-Feb-16 Australia has a supportive R&D environment and renowned academic institutions. The country outpaces the US in terms of medtech sales per capita: USD10.2 bn in 2012/13 for its 23 mn people, while US revenue was USD110 bn in 2015 for a population of 319 million. The top three therapeutic areas are cardiovascular, anesthesia, and musculoskeletal. [image: MD+DI]

04-Feb-16 SThe US and Europe are the traditional leaders in medtech, but others are hot on their heels. China's market is expected to grow at 7.4% until 2019. Medtech companies in Mexico save 19% on manufacturing costs compared with the US. Turkey's industry is expected to grow at 8.5% until 2018, and Malaysia supplies 80% of the world market for catheters. [image: MD+DI]

03-Feb-16 Italy's medical device companies are looking at the development potential in China, one of the markets where Italy's exports of medical devices have increased the most - by 24% in 2014 - with an export value of EUR310 mn (USD430 mn). Italian companies already present in China include DiaSorin, a biotech group specialized in in-vitro diagnostics. [image: Ambasciata d'Italia Pechino]

21-Jan-16 The Association of Malaysian Medical Industries (AMMI) supports the the Trans-Pacific Partnership, which it expects to provide wider access for exports into TPP countries, especially the US with which Malaysia has no trade agreement. Malaysia's medical devices industry mainly produces disposables, but is moving up the value chain and producing more high value medical devices such as orthopaedics and dialysers. [image: Hafzi Mohamed / TMR]

18-Jan-16 With policy support and a local talent pool, biomedicine may be the next big thing in Taiwan as President-elect Tsai Ing-wen takes office in May. Biotech is one of the five focus industries to be cultivated by the the new government, which will also invested in the development of drugs, medical instruments and materials. [image: University of Melbourne]